SEC FORM 4
$0.00
Tenaya Therapeutics, Inc. (TNYA)
Acquisition (code A) of 122,000 shares at $0 per share.
Reporting Person Ali Faraz · Officer Title Chief Executive Officer · Transaction Code A
Traded Sep 10, 2026 · Disclosed Sep 11, 2026
Source: SEC Form 4 · 0001193125-26-389563 · filed 2026-09-11 · View filing →